Credent Connect N Care Share Price & Stock Analysis

Quick Answers

What is the Credent Connect N Care share price today? Credent Connect N Care is currently listed and trading. Check our charts for the latest listing performance.

Is Credent Connect N Care a good stock to buy? Review our AI forensic scores and fundamental analysis for Credent Connect N Care to understand the underlying financial health.

Key Stock Information

ViewIPO AI Analysis Score

The Credent Connect N Care Stock scored 76/100 (Moderate Risk) in our deep analysis.

Frequently Asked Questions

What is the core business of Credent Connect N Care Limited?

Credent Connect N Care Limited provides integrated healthcare services including diagnostic sample logistics, phlebotomist and paramedical staffing, cold-chain transport, and corporate wellness programs.

What is the total issue size of the Credent Connect N Care IPO?

The issue size is ₹93.90 Crore, comprising entirely a fresh issue of 4,716,000 equity shares.

What are the subscription dates for Credent Connect N Care IPO?

The IPO opens for bidding on August 13, 2026, and closes on August 17, 2026.

What is the price band and lot size for the issue?

The price band is ₹179 to ₹189 per share, with a lot size of 600 shares.

How will the IPO proceeds be utilized?

Net proceeds will be used for working capital needs (₹37.00 Cr direct and subsidiary funding), subsidiary capital expenditure for machinery (₹3.00 Cr), and borrowing repayments (₹6.00 Cr).

Where will Credent Connect N Care Limited shares be listed?

The equity shares are proposed to be listed on the NSE EMERGE platform.

Who are the BRLM and Registrar for the IPO?

Hem Securities Limited is the Book Running Lead Manager, and KFin Technologies Limited is the Registrar to the issue.

Home›India›Credent Connect N Care ()
Credent Connect N Care Logo

Credent Connect N CareNSE SME / BSE SME:

Analyzed by ViewIPO Financial Research Team
HealthcareIndiaFiled 2026-08-13Listed 2026-08-20Size Pending Data
Listing Price ₹281

Is Credent Connect N Care a Good Stock? Quick Verdict

Credent Connect N Care IPO scored 76/100 (Moderate Risk) in our deep analysis. The strongest pillar is Promoter/Management at 90/100, while Competition is the primary concern at 55/100. Credent Connect N Care Limited displays strong revenue expansion and high return ratios, though investors should monitor working capital intensity and historical cash flow volatility.

Stock Score
76/100
Moderate Risk

Quick Verdict

Strong top-line expansion with FY2026 revenue reaching ₹214.16 Crore.
Exceptional return ratios featuring ROCE of 61.81% and ROE of 40.00%.
Working-capital-intensive operations with significant reliance on trade receivables.
Historical instances of negative operating cash flows in recent financial periods.

Company Snapshot

Revenue (TTM)
₹214.16Cr↑ 174.78% YoY
Profitability
PositiveNet Income ₹18.44Cr
Gross Margin
— 
Market Cap
₹89.1CrAt upper band ₹189
Issue Size
— 
Industry
Healthcare 
P/E Ratio
153.66xValuation Multiple
Return on Equity
40%Profitability
Debt to Equity
0.5xLeverage
EPS
₹33.12Earnings Per Share
NAV
₹33.12Net Asset Value
RoNW
42.13%Return on Net Worth

Risk Breakdown

Governance
65
Moderate
Financial
87
Excellent
Valuation
80
Excellent
Competition
55
Expensive
Dilution
80
Excellent
Promoter / Mgmt
90
Excellent

AI Summary

Credent Connect N Care Limited is an Indian healthcare services provider offering integrated logistics, phlebotomy staffing, cold-chain sample transport, and corporate wellness solutions across India. For FY2026, the company achieved revenue of ₹214.16 Crore and net profit of ₹18.44 Crore, marking substantial growth compared to prior fiscal periods. The company is raising ₹93.90 Crore through an entirely fresh issue to finance working capital requirements, subsidiary machinery capital expenditure, and debt repayment. While backed by impressive return metrics like ROCE of 61.81%, the business remains working-capital-intensive and reliant on healthcare sector demand.

Overall Verdict: Credent Connect N Care Limited displays strong revenue expansion and high return ratios, though investors should monitor working capital intensity and historical cash flow volatility.

Key Highlights

  • •Operates an integrated healthcare support platform combining diagnostic sample cold-chain logistics, staffing, and wellness programs.
  • •FY2026 annual revenue grew significantly to ₹214.16 Crore from ₹77.94 Crore in FY2025.
  • •Network comprises 2,589 riders and 97 commercial vehicles operating across Mumbai, Pune, Chennai, and Varanasi hubs.
  • •Net profit expanded to ₹18.44 Crore in FY2026, up from ₹2.24 Crore in FY2025.
  • •Total issue size is ₹93.90 Crore, structured completely as a fresh issue of shares.
  • •Pre-IPO promoter holding stands at 99.88%.

Financial Performance

Revenue (Annual)

↑ +174.8% YoY

INR in Crores

Net Income (Annual)

↑ +723.2% YoY

INR in Crores

EBITDA vs PAT

↑ +470.3% YoY

INR in Crores

EBITDA
PAT

Listing Timeline

IPO Opens2026-08-13
IPO Closes2026-08-17
Basis of Allotment2026-08-18
Refunds & Demat2026-08-19
Listing Date2026-08-20

Valuation Analysis

Issue Price₹179 - ₹189
Estimated Fair Value
Pending Data
Valuation Premium
Pending
vs Fair Value

Stock DNA

Growth
71
Governance
65
Profitability
87
Valuation
80
Competition
55
Execution
90

Pros vs Cons

Pros

  • Integrated healthcare offering combining cold-chain logistics, staffing, and corporate wellness services.
  • High profitability ratios with ROE of 40.00% and ROCE of 61.81%.
  • Substantial revenue expansion to ₹214.16 Crore in FY2026.
  • Conservative leverage position with a Debt-to-Equity ratio of 0.50x.

Cons

  • Significant operational reliance on the healthcare and diagnostic sector performance.
  • Working-capital-intensive operational structure with trade receivables forming a large part of assets.
  • History of negative operating cash flows in recent fiscal periods.
  • Pending legal proceedings involving the company, its directors, and promoters.

Financial Health

Revenue Growth
174.7% (FY25 to FY26) (Excellent)
Debt Level
0.50 Debt-to-Equity (Good)
Cash & Equivalents
Undisclosed (Moderate)

Institutional Signals

Anchor Investors
Yes
VC Backing Tier
Undisclosed
Founder Ownership
99.88%
Strategic Partners
Tier 2

Credent Connect N Care IPO Reddit Pulse & Sentiment

Real-time Reddit discussions & retail sentiment

No Public Data Available

We couldn't find any significant public discussions or retail sentiment threads for this IPO at the moment.

Disclaimer: These are raw community discussions aggregated from public forums. The AI summary and Reddit comments do not constitute financial advice. Always conduct your own independent research.

Credent Connect N Care Stock — Frequently Asked Questions

Related Stock Reports

Paramount Syntex

Paramount Syntex

PARAM
0/100
View Report
Nityas Gems & Jewellery

Nityas Gems & Jewellery

NITYA
0/100
View Report
Omara Ventures

Omara Ventures

OMARA
0/100
View Report
Sollfege Smart Electronics

Sollfege Smart Electronics

SOLLF
0/100
View Report
Dove Soft

Dove Soft

DOVE
0/100
View Report

Market Terminology Explained

Confused by terms like GMP, Kostak, or Subject to Sauda? Read our detailed guides in the IPO Glossary to understand the terminology before you invest.

View Full Glossary

Source Citation: All financial data and risk metrics are derived from the official prospectus filed with the regulator (SEBI DRHP/RHP). ViewIPO algorithms process this public data for informational purposes. Not financial advice.

Want to analyze another stock or IPO?

Search any stock, IPO, company, ticker or filing and get instant AI-powered analysis.

Frequently Asked Questions about Credent Connect N Care

What is the expected listing price of Credent Connect N Care?

The expected listing price depends on the live Grey Market Premium. Check the live GMP and expected listing price for Credent Connect N Care on our Live GMP Tracker.